Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Onyx spins off of Chiron and gets $5mm in first round

Executive Summary

Chiron spin-off Onyx Pharmaceuticals (oncology) raised $5mm through its first round of venture financing from Avalon Ventures, Institutional Venture Partners, JH Whitney, and Kleiner Perkins Caufield & Byers, which together hold a 42.8% stake.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies